Antifungal activity and mechanism of action of terbinafine

Reviews in Contemporary Pharmacotherapy

Volumn 8, Issue 5, 1997, Pages 275-287

  Ryder, Neil S ^a   Favre, Bertrand ^a  

^a NOVARTIS RESEARCH INSTITUTE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ENZYME INHIBITOR; ERGOSTEROL; FLUCONAZOLE; ITRACONAZOLE; PYRROLE DERIVATIVE; SQUALENE; SQUALENE MONOOXYGENASE; TERBINAFINE;

ANTIFUNGAL ACTIVITY; ASPERGILLUS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DERMATOPHYTE; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SENSITIVITY; DRUG STRUCTURE; EPOXIDATION; FUSARIUM; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PENICILLIUM; PNEUMOCYSTIS CARINII; REVIEW; STEROL SYNTHESIS; TRICHOSPORON BEIGELII;

EID: 0030657424     PISSN: 09548602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Ahmad A, Khan AK, Sultana S, Siddiqi SA, Haroon TS. In vitro antifungal studies of terbinafine. Pakistan J Sci Ind Res 1989; 32: 737-739.
2. Back DJ, Tjia JF, Abel SM. Azoles, allylamines and drug metabolism. Br J Dermatol 1992; 126 (Suppl 39): 14-18.
3. Balfour JA, Faulds D. Terbinafine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 1992; 43: 259-284.
4. Barrett-Bee K, Ryder NS. Biochemical aspects of ergosterol biosynthesis inhibition. In: Sutcliffe JA, Georgopapadakou NH, eds. Emerging targets for antibacterial and antifungal chemotherapy. New York: Chapman and Hall, 1992: 410-436.
5. Brodell RT, Elewski BE. Clinical pearl. Systemic antifungal drugs and drug interactions. J Am Acad Dermatol 1995; 33: 259-260.
6. Bryan CS, Smith CW, Berg DE, Karp RB. Curvularia lunata endocarditis treated with terbinafine - case report. Clin Infect Dis 1993; 16: 30-32.
7. Butty P, Lebecq JC, Mallie M, Bastide JM. Evaluation of the susceptibility of dermatophytes to antifungal drugs: a new technique. J Med Vet Mycol 1995; 33: 403-409.
8. Cirioni O, Giacometti A, Balducci M, Burzacchini F, Scalise G. In vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii. J Antimicrob Chemother 1995; 36: 740-742.
9. Clayton YM. The in vitro activity of terbinafine against uncommon fungal pathogens. In: Fromtling RA, ed. Recent trends in the discovery, development and evaluation of antifungal agents. Barcelona: J.R. Prous Science Publishers, 1987: 433-439.
10. Clayton YM. Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses. Br J Dermatol 1994; 130 (Suppl 43): 7-8.
11. Contini C, Manganaro M, Romani R et al. Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia. J Antimicrob Chemother 1994; 34: 727-735.
12. Cox NH, Irving B. Cutaneous 'ringworm' lesions of Scopulariopsis brevicaulis. Br J Dermatol 1993; 129: 726-728.
13. De Hoog GS, Matsumoto T, Matsuda T, Uijthof JMJ. Exophiala jeanselmei var. lecanii-corni, an etiologic agent of human phaeohyphomycosis, with report of a case. J Med Vet Mycol 1994; 32: 373-380.
14. Dixon DM, Polak A. In vitro and in vivo drug studies with three agents of central nervous system phaeohyphomycosis. Chemotherapy 1987; 33: 129-140.
15. Engelkens HJH, Naafs B. Mycetoma. Br J Dermatol 1994; 131: 722-723.
16. Esterre P, Inzan CK, Ramarcel ER et al. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol 1996; 134 (Suppl 46): 33-36.
17. Favre B, Ryder NS. Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents. Antimicrob Agents Chemother 1996; 40: 443-447.
18. Favre B, Ryder NS. Cloning and expression of squalene epoxidase from the pathogenic yeast Candida albicans. Gene 1997; 189: 119-126..
19. Foss NT, Rocha MRO, Lima VTA, Velludo MASL, Roselino AMF. Entomophthoramycosis: Therapeutic success by using amphotericin B and terbinafine. Dermatology 1996; 193: 258-260.